应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BK1593
0.000
+0.000
--
最高
0.000
最低
0.000
成交量
0.00
今开
0.000
昨收
0.000
日振幅
0.00%
总市值
0.00
流通市值
0.00
总股本
0.00
成交额
0.00
换手率
--
流通股本
0.00
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
昊海生物科技(06826)12月23日斥资29.13万港元回购1.1万股
智通财经 · 47分钟前
昊海生物科技(06826)12月23日斥资29.13万港元回购1.1万股
三生制药12月23日收盘下跌0.33%,成交2213.99万港元
金融界 · 51分钟前
三生制药12月23日收盘下跌0.33%,成交2213.99万港元
四环医药12月23日遭主力抛售299万元 环比增加595.35%
市场透视 · 16:16
四环医药12月23日遭主力抛售299万元 环比增加595.35%
重磅药品种抢滩!石四药第三家过评,奥赛康、豪森、复星等积极布局,诺华能否抗住冲击?
医药经济报 · 09:52
重磅药品种抢滩!石四药第三家过评,奥赛康、豪森、复星等积极布局,诺华能否抗住冲击?
南向资金12月20日净买入四环医药22.70万股 连续3日增持
市场透视 · 09:30
南向资金12月20日净买入四环医药22.70万股 连续3日增持
复宏汉霖将完成私有化:拟明年2月初退市 成复星旗下又一摘牌企业
雷递 · 12-22 22:03
复宏汉霖将完成私有化:拟明年2月初退市 成复星旗下又一摘牌企业
云南瑞丽4人一氧化碳中毒窒息,1人死亡、3人仍在救治
媒体滚动 · 12-22 19:02
云南瑞丽4人一氧化碳中毒窒息,1人死亡、3人仍在救治
复星医药寄发有关以吸收合并复宏汉霖并私有化的文件
观点网 · 12-22 18:34
复星医药寄发有关以吸收合并复宏汉霖并私有化的文件
现代牙科12月20日耗资41.5万港元回购10万股
格隆汇 · 12-20 18:27
现代牙科12月20日耗资41.5万港元回购10万股
现代牙科(03600)12月20日斥资41.5万港元回购10万股
智通财经 · 12-20 18:06
现代牙科(03600)12月20日斥资41.5万港元回购10万股
昊海生物科技(06826)12月20日斥资107.05万港元回购4万股
智通财经网 · 12-20
昊海生物科技(06826)12月20日斥资107.05万港元回购4万股
康哲药业12月20日收盘上涨0.14%,成交4717.7万港元
金融界 · 12-20
康哲药业12月20日收盘上涨0.14%,成交4717.7万港元
三生制药12月20日主力资金流出89万元 连续5日减仓
市场透视 · 12-20
三生制药12月20日主力资金流出89万元 连续5日减仓
三生制药多款产品续约医保,研发管线进展加速
长城证券 · 12-20
三生制药多款产品续约医保,研发管线进展加速
医思健康盘中异动 快速跳水5.63%
市场透视 · 12-20
医思健康盘中异动 快速跳水5.63%
南向资金12月19日净买入复星医药74.10万股 连续3日增持
市场透视 · 12-20
南向资金12月19日净买入复星医药74.10万股 连续3日增持
复星医药子公司复宏汉霖与Palleon签署许可协议
北京商报 · 12-19
复星医药子公司复宏汉霖与Palleon签署许可协议
现代牙科(03600)12月19日斥资41.39万港元回购10万股
智通财经 · 12-19
现代牙科(03600)12月19日斥资41.39万港元回购10万股
复星医药(600196.SH)与Palleon签订合作与许可协议 拟开展许可产品联合汉利康®临床研究
智通财经 · 12-19
复星医药(600196.SH)与Palleon签订合作与许可协议 拟开展许可产品联合汉利康®临床研究
复星医药:控股子公司签署药品合作与许可协议
美港电讯 · 12-19
复星医药:控股子公司签署药品合作与许可协议
加载更多
公司概况
公司名称:
BK1593
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"BK1593","market":"HK","secType":"PLATE","latestPrice":0,"timestamp":0,"preClose":0,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatusCode":0,"change":0,"open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"adr":0,"adjPreClose":0},"requestUrl":"/m/hq/s/BK1593","defaultTab":"news","newsList":[{"id":"2493736574","title":"昊海生物科技(06826)12月23日斥资29.13万港元回购1.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2493736574","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493736574?lang=zh_cn&edition=full","pubTime":"2024-12-23 17:06","pubTimestamp":1734944785,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昊海生物科技(06826)发布公告,于2024年12月23日,该公司斥资29.13万港元回购1.1万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1228419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06826","BK1593"],"gpt_icon":0},{"id":"2493739382","title":"三生制药12月23日收盘下跌0.33%,成交2213.99万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493739382","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493739382?lang=zh_cn&edition=full","pubTime":"2024-12-23 17:02","pubTimestamp":1734944567,"startTime":"0","endTime":"0","summary":"12月23日,截至港股收盘,恒生指数上涨0.82%,报19883.13点。三生制药收报6.03港元/股,下跌0.33%,成交量365.7万股,成交额2213.99万港元,振幅2.31%。最近一个月来,三生制药累计涨幅9.24%,今年来累计跌幅16.64%,跑输恒生指数16.63%的涨幅。财务数据显示,截至2024年6月30日,三生制药实现营业总收入43.89亿元,同比增长16.01%;归母净利润10.9亿元,同比增长11.15%;毛利率86.51%,资产负债率29.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223170511a2044759&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223170511a2044759&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","01530","BK1583"],"gpt_icon":0},{"id":"2493510738","title":"四环医药12月23日遭主力抛售299万元 环比增加595.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493510738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493510738?lang=zh_cn&edition=full","pubTime":"2024-12-23 16:16","pubTimestamp":1734941808,"startTime":"0","endTime":"0","summary":"12月23日, 四环医药股价跌1.52%,报收0.65元,成交金额1011万元,换手率0.17%,振幅3.03%,量比1.32。四环医药今日主力资金净流出299万元,连续3日净流出,上一交易日主力净流出43万元,今日环比增加595.35%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为50.00%,平均跌幅为2.95%。该股近5个交易日下跌4.48%,主力资金累计净流出537万元;近20日主力资金累计净流出344万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223161715ab8d67e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223161715ab8d67e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1600","BK1515","00460","BK1191"],"gpt_icon":0},{"id":"2493427085","title":"重磅药品种抢滩!石四药第三家过评,奥赛康、豪森、复星等积极布局,诺华能否抗住冲击?","url":"https://stock-news.laohu8.com/highlight/detail?id=2493427085","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493427085?lang=zh_cn&edition=full","pubTime":"2024-12-23 09:52","pubTimestamp":1734918762,"startTime":"0","endTime":"0","summary":"业内观点认为,石四药作为国内第三家获批地拉罗司分散片仿制药的企业,将直接参与分割原研药的国内市场份额,并与此前已经获批的江苏奥赛康药业和中美华世通生物医药掀起新一轮市场竞争;此外,包括江苏豪森、复星医药等在内的国内巨头药企均在积极推进产品布局。2022年5月13日,NMPA发布药品批准证明文件待领取信息,其中,江苏豪森药业两款仿制药品种获批上市,分别为地拉罗司片和氢溴酸伏硫西汀片。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223095707ab8c9c8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223095707ab8c9c8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1593","02005","02196","BK1191"],"gpt_icon":0},{"id":"2493272294","title":"南向资金12月20日净买入四环医药22.70万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2493272294","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493272294?lang=zh_cn&edition=full","pubTime":"2024-12-23 09:30","pubTimestamp":1734917410,"startTime":"0","endTime":"0","summary":"12月20日, 南向资金增持四环医药22.70万股,连续3日增持。截止当日收盘,港股通共持有四环医药82097.01万股,占流通股8.79%。港股通增持金额前五个股分别为中国移动、工商银行、建设银行、中通快递-W、中国海洋石油。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223093051a2034d05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223093051a2034d05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1191","BK1600","00460","BK1515"],"gpt_icon":0},{"id":"2493443042","title":"复宏汉霖将完成私有化:拟明年2月初退市 成复星旗下又一摘牌企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2493443042","media":"雷递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493443042?lang=zh_cn&edition=full","pubTime":"2024-12-22 22:03","pubTimestamp":1734876201,"startTime":"0","endTime":"0","summary":"雷递网 雷建平 12月22日在宝宝树被强制退市,复星旅文宣布要私有化之际,复星旗下上市企业复宏汉霖的私有化也取得积极进展。截至今日,复宏汉霖股价为23.9港元,市值为129.9亿港元。截至目前,复宏汉霖处于停牌阶段,公司股价为18.84港元,市值为102亿港元。复星旅文称,此次私有化提案是基于复星旅文长期发展战略所做出的关键决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241222221641a202489a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241222221641a202489a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","02196","BK1191","02696","BK1515"],"gpt_icon":0},{"id":"2493624898","title":"云南瑞丽4人一氧化碳中毒窒息,1人死亡、3人仍在救治","url":"https://stock-news.laohu8.com/highlight/detail?id=2493624898","media":"媒体滚动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493624898?lang=zh_cn&edition=full","pubTime":"2024-12-22 19:02","pubTimestamp":1734865320,"startTime":"0","endTime":"0","summary":"转自:上观新闻记者从云南省瑞丽市委宣传部获悉,22日早晨,瑞丽市勐秀乡南京里村干吕村民小组一民房内,有4人因一氧化碳中毒导致窒息。其中1人救治无效死亡,另外3人目前仍在救治当中。据介绍,经现场初步勘验核查,窒息人员符合一氧化碳中毒症状,4人均为缅甸籍务工人员,在瑞丽市一家餐馆工作。瑞丽市21日晚间气温较低,4人在房间内烧炭取暖。22日早晨,餐馆负责人发现4人未正常上班,随后敲门发现异常。目前,伤者救治、死者善后等工作正在开展。栏目主编:张武 文字编辑:董思韵 \n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-12-22/doc-ineaiuqp3516238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1209","BK1593","02135"],"gpt_icon":0},{"id":"2493107842","title":"复星医药寄发有关以吸收合并复宏汉霖并私有化的文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2493107842","media":"观点网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493107842?lang=zh_cn&edition=full","pubTime":"2024-12-22 18:34","pubTimestamp":1734863640,"startTime":"0","endTime":"0","summary":"观点网讯:12月22日,上海复星医药(集团)股份有限公司、上海复宏汉霖生物技术股份有限公司发布联合公告,宣布寄发有关以吸收合并复宏汉霖方式,由复星新药对复宏汉霖私有化建议的综合文件。根据公告,综合文件已于同日寄发,详细阐述了私有化的具体条款和条件。此次私有化临时股东大会及H股类别股东大会的日期定于2025年1月22日,股份过户登记手续将从2025年1月17日暂停至同月22日。经独立董事委员会批准,董事会已委任浤博资本有限公司为独立财务顾问,以就合并向独立董事委员会提供意见 。预计所有生效条件将在2025年1月22日达成,届时H股在联交所的最后交易日为2025年2月4日下午4时10分。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241222184108ab8b37e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241222184108ab8b37e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02696","02196","BK1515","BK1161","BK1593","BK1191","600196"],"gpt_icon":0},{"id":"2492241369","title":"现代牙科12月20日耗资41.5万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492241369","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492241369?lang=zh_cn&edition=full","pubTime":"2024-12-20 18:27","pubTimestamp":1734690428,"startTime":"0","endTime":"0","summary":"格隆汇12月20日丨现代牙科(03600.HK)公告,12月20日耗资41.5万港元回购10万股。【免责声明】本文仅代表作者本人观点,与和讯网无关。和讯网站对文中陈述、观点判断保持中立,不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。邮箱:news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220183331a1fd8265&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220183331a1fd8265&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","03600","BK1100","BK1593"],"gpt_icon":0},{"id":"2492497724","title":"现代牙科(03600)12月20日斥资41.5万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492497724","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492497724?lang=zh_cn&edition=full","pubTime":"2024-12-20 18:06","pubTimestamp":1734689202,"startTime":"0","endTime":"0","summary":"智通财经APP讯,现代牙科(03600)发布公告,于2024年12月20日,该公司斥资41.5万港元回购10万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227756.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK1583","BK1100","03600"],"gpt_icon":0},{"id":"2492923814","title":"昊海生物科技(06826)12月20日斥资107.05万港元回购4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492923814","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492923814?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:18","pubTimestamp":1734686280,"startTime":"0","endTime":"0","summary":"昊海生物科技(06826)发布公告,于2024年12月20日该公司斥资107.05万港元回购4万股,回购价格为每股26.70-26.85港元。于2024年12月20日该公司斥资人民币198.62万元回购3.2万股A股,回购价格为每股人民币61.94-62.20元。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-20/doc-ineacaar9109509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06826","BK1161","BK1593"],"gpt_icon":0},{"id":"2492152492","title":"康哲药业12月20日收盘上涨0.14%,成交4717.7万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492152492","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492152492?lang=zh_cn&edition=full","pubTime":"2024-12-20 16:43","pubTimestamp":1734684197,"startTime":"0","endTime":"0","summary":"12月20日,截至港股收盘,恒生指数下跌0.16%,报19720.7点。康哲药业收报7.41港元/股,上涨0.14%,成交量638.05万股,成交额4717.7万港元,振幅2.97%。最近一个月来,康哲药业累计跌幅3.9%,今年来累计跌幅44.66%,跑输恒生指数15.87%的涨幅。财务数据显示,截至2024年6月30日,康哲药业实现营业总收入36.11亿元,同比减少21.67%;归母净利润9.1亿元,同比减少52.61%;毛利率74.67%,资产负债率12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220171308a1fd48c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220171308a1fd48c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015952.SGD","00867","SG9999015978.USD","IE00BYV24P56.USD","LU2488822045.USD","BK1191","SG9999004220.SGD","IE00BMCWC346.EUR","BK1593","SG9999015986.USD","SG9999015945.SGD"],"gpt_icon":0},{"id":"2492494641","title":"三生制药12月20日主力资金流出89万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2492494641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492494641?lang=zh_cn&edition=full","pubTime":"2024-12-20 16:16","pubTimestamp":1734682619,"startTime":"0","endTime":"0","summary":"12月20日, 三生制药股价跌0.82%,报收6.05元,成交金额4765万元,换手率0.33%,振幅2.30%,量比1.25。三生制药今日主力资金净流出89万元,连续5日净流出,上一交易日主力净流出276万元,今日环比减少67.75%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为20.00%,平均跌幅为1.43%。该股近5个交易日下跌2.60%,主力资金累计净流出949万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出251万元,其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220162020a1fd29a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220162020a1fd29a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1593","BK1161","01530"],"gpt_icon":0},{"id":"2492454176","title":"三生制药多款产品续约医保,研发管线进展加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2492454176","media":"长城证券","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492454176?lang=zh_cn&edition=full","pubTime":"2024-12-20 11:16","pubTimestamp":1734664582,"startTime":"0","endTime":"0","summary":"2024年国家医保目录结果公布,公司多款产品成功续约/新增。公司生发产品长期增长,蔓迪下半年收入预期提速。蔓迪新款泡沫剂年中在全平台发售,当前销售推向均优先导向泡沫剂。公司围绕蔓迪采取多元化的线上、线下销售策略,预期下半年相关收入有望提速。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220113043a1fca8a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220113043a1fca8a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1593","01530"],"gpt_icon":0},{"id":"2492451184","title":"医思健康盘中异动 快速跳水5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492451184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492451184?lang=zh_cn&edition=full","pubTime":"2024-12-20 11:05","pubTimestamp":1734663946,"startTime":"0","endTime":"0","summary":"2024年12月20日早盘11时05分,医思健康股票出现波动,股价快速下挫5.63%。截至发稿,该股报0.670港元/股,成交量9.3万股,换手率0.01%,振幅4.23%。资金方面,该股资金流入0港元,流出2.963万港元。医思健康股票所在的医疗及医学美容服务行业中,整体跌幅为0.26%。其相关个股中,熙康云医院、中国生物科技服务、麦迪卫康涨幅较大,振幅较大的相关个股有康健国际医疗、清晰医疗、雍禾医疗,振幅分别为9.17%、5.19%、4.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220110546ab85e300&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220110546ab85e300&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1215","BK1511","02138"],"gpt_icon":0},{"id":"2492458667","title":"南向资金12月19日净买入复星医药74.10万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2492458667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492458667?lang=zh_cn&edition=full","pubTime":"2024-12-20 09:30","pubTimestamp":1734658219,"startTime":"0","endTime":"0","summary":"12月19日, 南向资金增持复星医药74.10万股,连续3日增持。截止当日收盘,港股通共持有复星医药30943.60万股,占流通股56.05%。港股通增持金额前五个股分别为建设银行、中国移动、中国海洋石油、工商银行、农业银行。复星医药近5个交易日下跌4.12%,港股通累计增持238.15万股;近20个交易日下跌3.99%,港股通累计增持629.09万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220093610ab85b0a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220093610ab85b0a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","02196","BK1191","BK1593","600196"],"gpt_icon":0},{"id":"2492120570","title":"复星医药子公司复宏汉霖与Palleon签署许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2492120570","media":"北京商报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492120570?lang=zh_cn&edition=full","pubTime":"2024-12-19 20:57","pubTimestamp":1734613061,"startTime":"0","endTime":"0","summary":"12月19日晚间,复星医药发布公告称,公司控股子公司复宏汉霖与Palleon签订《合作与许可协议》,根据约定,双方将基于各自专利及专有技术,就Palleon在研产品E-602及相关联合治疗方案于领域内的全球合作开发及于各自许可区域内的商业化开展合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219210704a1fb320f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219210704a1fb320f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1593","BK1191","02196","BK1161","02696"],"gpt_icon":0},{"id":"2492680123","title":"现代牙科(03600)12月19日斥资41.39万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492680123","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492680123?lang=zh_cn&edition=full","pubTime":"2024-12-19 19:07","pubTimestamp":1734606458,"startTime":"0","endTime":"0","summary":"智通财经APP讯,现代牙科(03600)发布公告,于2024年12月19日斥资41.39万港元回购股份10万股,每股回购价格为4.11-4.15港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227218.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK1100","03600","BK1583"],"gpt_icon":0},{"id":"2492140822","title":"复星医药(600196.SH)与Palleon签订合作与许可协议 拟开展许可产品联合汉利康®临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2492140822","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492140822?lang=zh_cn&edition=full","pubTime":"2024-12-19 18:27","pubTimestamp":1734604060,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复星医药 发布公告,公司控股子公司复宏汉霖与Palleon签订《合作与许可协议》,根据约定,双方将基于各自专利及专有技术,就Palleon在研产品E-602及相关联合治疗方案于领域内的全球合作开发及于各自许可区域内的商业化开展合作。截至本公告日期,许可产品用于治疗晚期癌症患者的I/II期临床试验正由Palleon于美国开展。复宏汉霖拟于《合作与许可协议》签订后,开展许可产品联合汉利康用于治疗狼疮肾炎的临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227168.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0183","BK0028","BK0175","BK0188","BK0239","BK0012","BK1515","BK0187","BK0196","BK1593","02196","BK1191","BK0096","600196","BK0060"],"gpt_icon":0},{"id":"2492147708","title":"复星医药:控股子公司签署药品合作与许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2492147708","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492147708?lang=zh_cn&edition=full","pubTime":"2024-12-19 18:27","pubTimestamp":1734604032,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1161","BK1191","BK1593","BK1583","02196","BK0239","03347","BK0188","600196","BK0012","BK1576","BK0196","BK0175","BK0187","BK0028","BK0060","BK0183","BK0096","BK1515","02696","BK1141"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0125},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0801},{"period":"6month","weight":0.0939},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1568}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"name":"BK1593","nameEN":"BK1593"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"undefined(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供undefined(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":",BK1593,股票,股票老虎,股票老虎国际,行情,股票行情,股价,股市,股票价格,股票交易,股票购买,股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"undefined(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供undefined(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}